Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health Catalyst (HCAT) EPS (Basic) (2018 - 2025)

Health Catalyst (HCAT) has disclosed EPS (Basic) for 8 consecutive years, with -$0.32 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EPS (Basic) fell 33.33% year-over-year to -$0.32, compared with a TTM value of -$1.59 through Sep 2025, down 18.66%, and an annual FY2024 reading of -$1.15, up 44.98% over the prior year.
  • EPS (Basic) was -$0.32 for Q3 2025 at Health Catalyst, up from -$0.59 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$0.23 in Q2 2024 and bottomed at -$0.96 in Q4 2021.
  • Average EPS (Basic) over 5 years is -$0.54, with a median of -$0.58 recorded in 2023.
  • The sharpest move saw EPS (Basic) surged 60.34% in 2024, then plummeted 156.52% in 2025.
  • Year by year, EPS (Basic) stood at -$0.96 in 2021, then surged by 30.21% to -$0.67 in 2022, then rose by 22.39% to -$0.52 in 2023, then soared by 36.54% to -$0.33 in 2024, then increased by 3.03% to -$0.32 in 2025.
  • Business Quant data shows EPS (Basic) for HCAT at -$0.32 in Q3 2025, -$0.59 in Q2 2025, and -$0.35 in Q1 2025.